Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25383676 | 0.82 | ALDH1A1 (0.44) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL25385087 | 0.82 | ALDH1A1 (0.44) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL25383674 | 0.82 | ALDH1A1 (0.44) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL25383670 | 0.82 | ALDH1A1 (0.44) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL27176929 | 0.79 | KDM4E (0.42) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL31160040 | 0.78 | POLB (0.40) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL31159766 | 0.78 | ALDH1A1 (0.40) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL30966733 | 0.76 | HPGD (0.36) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL27255582 | 0.76 | HPGD (0.36) | KMT2AKDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL29170113 | 0.75 | MAPT (0.46) | KMT2AKDM4EALDH1A1HPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688144-A1 | COMPOUNDS AS GLP-1R AGONISTS | Terns Pharmaceuticals, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024206878-A1 | COMPOUNDS AS GLP-1R AGONISTS | TERNS PHARMACEUTICALS, INC. (US) | 2024-10-03 | — | — | WO | disclosed |